Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Capital Expenditures (2020 - 2024)

RAPT Therapeutics' Capital Expenditures history spans 5 years, with the latest figure at $1000.0 for Q4 2024.

  • For Q4 2024, Capital Expenditures fell 98.51% year-over-year to $1000.0; the TTM value through Dec 2024 reached $122000.0, down 89.16%, while the annual FY2024 figure was $122000.0, 89.16% down from the prior year.
  • Capital Expenditures for Q4 2024 was $1000.0 at RAPT Therapeutics, down from $17000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $759000.0 in Q1 2023 and bottomed at -$1000.0 in Q2 2024.
  • The 5-year median for Capital Expenditures is $98000.0 (2020), against an average of $170789.5.
  • The largest annual shift saw Capital Expenditures skyrocketed 784.38% in 2022 before it tumbled 100.43% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $174000.0 in 2020, then surged by 126.44% to $394000.0 in 2021, then crashed by 87.56% to $49000.0 in 2022, then skyrocketed by 36.73% to $67000.0 in 2023, then crashed by 98.51% to $1000.0 in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Capital Expenditures are $1000.0 (Q4 2024), $17000.0 (Q3 2024), and -$1000.0 (Q2 2024).